Search

everythinglearnresearchcommunity

for

Search:↓

Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.

The AndroCoV Clinical Scoring is an accurate, easy, and free way to diagnose COVID-19 without a lab test.

The study concludes that the new clinical scoring system is a quick, low-cost, and accurate method for diagnosing COVID-19.

The AndroCoV Clinical Scoring is a quick, affordable, and accurate method for diagnosing COVID-19.

Brain-Derived Neurotrophic Factor (BDNF) slows down hair growth and promotes hair follicle regression.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Hoxc13 is linked to seasonal hair growth in Cashmere goats and is affected by melatonin.

Certain proteins involved in DNA modification may affect the genetic changes in systemic lupus erythematosus and could indicate the disease's activity.

Innovative methods are reducing animal testing and improving biomedical research.

Cattle skin has leptin which might control skin and hair growth.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

A woman's shingles infection triggered her first episode of a rare neurological disorder and blood vessel inflammation.

IL-36α helps in growing new hair follicles when healing wounds, potentially aiding in hair growth.

Modulating Cytochrome P450 activity could help develop new skin disease treatments.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

The study found specific skin and cell changes in patients with monkeypox, helping diagnose and understand the disease.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

Stress-related substance P may lead to hair loss and negatively affect hair growth.

Blue light promotes hair growth by interacting with specific receptors in hair follicles.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

Human hair follicles contain a complex network of prostanoid receptors that may influence hair growth.

Dihydrotestosterone increases certain inflammatory signals in skin cells, potentially contributing to acne.